Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

Presentation AHA 2023

Effects of intensive blood pressure lowering treatment in reducing risk of cardiovascular events

Presenter: Jing Li

November 16, 2023

Presentation AHA 2023

Dapagliflozin in myocardial infarction without diabetes or heart failure

Presenter: Stefan James

November 14, 2023

Presentation TCT 2023

TCT 491: Diabetes mellitus as an independent risk for death and stroke in hypertrophic cardiomyopathy

Presenter: Said hajouli

October 26, 2023

Presentation TCT 2023

Challenging Cases treated with DES+DCB Stent Platform

Presenter: Ricardo Costa

October 26, 2023

Presentation TCT 2023

ABILITY DIABETES GLOBAL RCT: Study Updates

Presenter: Marie-Claude Morice

October 26, 2023

Presentation TCT 2023

Tailored to treat diabetes: The gamechanger Envisolution Technology

Presenter: Alexandre Abizaid

October 26, 2023

Presentation TCT 2023

Global Epidemic of Diabetes and the unmet need for Novel Stents for PCI

Presenter: Roxana Mehran

October 26, 2023

Optimal Revascularization Strategies in Patient with DM: Case Presentation

Presentation TCT 2023

Complex PCI in patients with DM: Cases Presentation

Presenter: Luca Testa

October 26, 2023

Presentation TCT 2023

Treatment of Patients With Diabetes and Diffuse Disease – Current Limitations

Presenter: Giulio Stefanini

October 26, 2023

Presentation TCT 2023

TCT 418: Impact of diabetes on clinical outcomes after percutaneous coronary intervention: 5-year results of the SORTOUT IX trial comparing the polymer-free biolimus A9-coated stent to the ultra-thin strut biodegradable polymer sirolimus-eluting stent

Presenter: Kirstine Hansen

October 25, 2023

Presentation TCT 2023

TCT 708: Five-Year Outcomes of Patients With Diabetes Mellitus Treated With a Sirolimus-Eluting or a Biolimus-Eluting Stents With Biodegradable Polymer. From the SORT OUT VII Trial

Presenter: Jens Trøan

October 25, 2023

Presentation TCT 2023

TCT 521: Comparison of 3-year outcomes between patients with acute myocardial infarction, nonobstructive coronary arteries, and diabetes versus non-diabetes

Presenter: Ae-Young Her

October 25, 2023

Presentation TCT 2023

TCT 140: Combined Coexistence of Multiple Vulnerable Plaque Features is Associated with Incremental Rates of Adverse Events in Patients with Diabetes Mellitus. New Insights From the COMBINE OCT-FFR trial

Presenter: David del Val

October 25, 2023

Presentation TCT 2023

TCT 168: Clinical Significance of Insulin Dependent and Non-insulin Dependent Diabetes in Patients Undergoing Prercutaneous Revascularization of the Left Main Coronary Artery

Presenter: Anastasios Roumeliotis

October 25, 2023

Presentation TCT 2023

TCT 721: The impact of Diabetes Mellitus on Carotid Artery Stenting: An updated Systematic Review and Meta-analysis

Presenter: Irfan Ullah

October 24, 2023

Presentation TCT 2023

TCT 729: Coronary Microvascular Function Characteristics in Patients With Diabetes Mellitus and Functionally Deferred PCI

Presenter: Alice Benedetti

October 24, 2023

Presentation TCT 2023

TCT 336: Routine Surveillance Stress Testing in High-Risk Patients with Diabetes After Percutaneous Coronary Intervention

Presenter: Hoyun Kim

October 24, 2023

Presentation ACC 2023

A Cluster-Randomized Trial to Improve Care of Patients in Cardiology Clinics with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease [COORDINATE-Diabetes]

Presenter: Neha J. Pagidipati

March 05, 2023

Advertisement

Effects of intensive blood pressure lowering treatment in reducing risk of cardiovascular events

Dapagliflozin in myocardial infarction without diabetes or heart failure

TCT 491: Diabetes mellitus as an independent risk for death and stroke in hypertrophic cardiomyopathy

Challenging Cases treated with DES+DCB Stent Platform

ABILITY DIABETES GLOBAL RCT: Study Updates

Tailored to treat diabetes: The gamechanger Envisolution Technology

Global Epidemic of Diabetes and the unmet need for Novel Stents for PCI

Complex PCI in patients with DM: Cases Presentation

Treatment of Patients With Diabetes and Diffuse Disease – Current Limitations

TCT 418: Impact of diabetes on clinical outcomes after percutaneous coronary intervention: 5-year results of the SORTOUT IX trial comparing the polymer-free biolimus A9-coated stent to the ultra-thin strut biodegradable polymer sirolimus-eluting stent

TCT 708: Five-Year Outcomes of Patients With Diabetes Mellitus Treated With a Sirolimus-Eluting or a Biolimus-Eluting Stents With Biodegradable Polymer. From the SORT OUT VII Trial

TCT 521: Comparison of 3-year outcomes between patients with acute myocardial infarction, nonobstructive coronary arteries, and diabetes versus non-diabetes

TCT 140: Combined Coexistence of Multiple Vulnerable Plaque Features is Associated with Incremental Rates of Adverse Events in Patients with Diabetes Mellitus. New Insights From the COMBINE OCT-FFR trial

TCT 168: Clinical Significance of Insulin Dependent and Non-insulin Dependent Diabetes in Patients Undergoing Prercutaneous Revascularization of the Left Main Coronary Artery

TCT 721: The impact of Diabetes Mellitus on Carotid Artery Stenting: An updated Systematic Review and Meta-analysis

TCT 729: Coronary Microvascular Function Characteristics in Patients With Diabetes Mellitus and Functionally Deferred PCI

TCT 336: Routine Surveillance Stress Testing in High-Risk Patients with Diabetes After Percutaneous Coronary Intervention

A Cluster-Randomized Trial to Improve Care of Patients in Cardiology Clinics with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease [COORDINATE-Diabetes]

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content